1. Home
  2. ACR vs ACTU Comparison

ACR vs ACTU Comparison

Compare ACR & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACR
  • ACTU
  • Stock Information
  • Founded
  • ACR 2005
  • ACTU 2015
  • Country
  • ACR United States
  • ACTU United States
  • Employees
  • ACR N/A
  • ACTU N/A
  • Industry
  • ACR Real Estate Investment Trusts
  • ACTU
  • Sector
  • ACR Real Estate
  • ACTU
  • Exchange
  • ACR Nasdaq
  • ACTU NYSE
  • Market Cap
  • ACR 139.0M
  • ACTU 135.0M
  • IPO Year
  • ACR N/A
  • ACTU 2024
  • Fundamental
  • Price
  • ACR $17.78
  • ACTU $6.15
  • Analyst Decision
  • ACR Buy
  • ACTU Strong Buy
  • Analyst Count
  • ACR 2
  • ACTU 1
  • Target Price
  • ACR $17.50
  • ACTU $20.00
  • AVG Volume (30 Days)
  • ACR 79.2K
  • ACTU 150.8K
  • Earning Date
  • ACR 07-30-2025
  • ACTU 05-15-2025
  • Dividend Yield
  • ACR N/A
  • ACTU N/A
  • EPS Growth
  • ACR N/A
  • ACTU N/A
  • EPS
  • ACR 0.34
  • ACTU N/A
  • Revenue
  • ACR $83,545,000.00
  • ACTU N/A
  • Revenue This Year
  • ACR $3.57
  • ACTU N/A
  • Revenue Next Year
  • ACR N/A
  • ACTU N/A
  • P/E Ratio
  • ACR $52.11
  • ACTU N/A
  • Revenue Growth
  • ACR 6.92
  • ACTU N/A
  • 52 Week Low
  • ACR $13.26
  • ACTU $5.50
  • 52 Week High
  • ACR $23.81
  • ACTU $11.99
  • Technical
  • Relative Strength Index (RSI)
  • ACR 47.60
  • ACTU N/A
  • Support Level
  • ACR $17.59
  • ACTU N/A
  • Resistance Level
  • ACR $18.10
  • ACTU N/A
  • Average True Range (ATR)
  • ACR 0.47
  • ACTU 0.00
  • MACD
  • ACR 0.05
  • ACTU 0.00
  • Stochastic Oscillator
  • ACR 51.44
  • ACTU 0.00

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: